Skip to main content

Together we are beating cancer

Donate now

Health service policy

Showing 12 out of 299 results

NICE has published draft guidance stating that the breast cancer drug trastuzumab emtansine (also known as Kadcyla) won't be routinely available through the NHS NICE has published draft guidance stating that the breast cancer drug trastuzumab emtansine (also known as Kadcyla) won't be routinely available through the NHS

by Cancer Research UK | News | 29 December 2016

29 December 2016

Mobile phone
  • Science & Technology
  • Health & Medicine

7 tweets that defined cancer policy in 2016

We pick out 7 top stories from the world of cancer policy and politics that defined 2016. We pick out 7 top stories from the world of cancer policy and politics that defined 2016.

by Roxy Squire | Analysis | 22 December 2016

22 December 2016

Cancer Research UK logo

NHS England has announced that it will invest £130m in new radiotherapy machines. Read why that investment is so important. NHS England has announced that it will invest £130m in new radiotherapy machines. Read why that investment is so important.

by Emlyn Samuel | Analysis | 25 October 2016

25 October 2016